Steven M. Bromidge - Concepedia

Concepedia

Author

Steven M. Bromidge

Molecular Discovery (United Kingdom)

Also Known As

S. BROMIDGE, S. Bromidge, S. M. BROMIDGE, S. M. Bromidge, S.M. Bromidge, Steven Bromidge, Steven M Bromidge, Steven M. Bromidge

70

Publications

3.1K

Citations

25

H-Index

49

Concepts

All Affiliations

Molecular Discovery (United Kingdom)GlaxoSmithKline (United Kingdom)New Frontier GlaxoSmithKline (Italy)

SM

About

Steven M. Bromidge is an author at Molecular Discovery (United Kingdom) specializing in pharmacology, medicine, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	29	2.3K
2	Biochemistry	15	18	1.1K
3	Natural Sciences	13	15	872
4	Engineering	3	3	73
5	Social Sciences	2	2	285

Steven M. Bromidge

×

40

Publications

3.1K

Citations

25

H-Index

	Year	Citations
SB 242084, a Selective and Brain Penetrant 5-HT 2C Receptor Antagonist G.A. Kennett, Martyn Wood, Fiona Bright, Neuropharmacology Sb 242084Molecular PharmacologyFunctional SelectivityMedicineReceptor Antagonist	1997	523
Characterization of SB‐269970‐A, a selective 5‐HT<sub>7</sub> receptor antagonist Jim J. Hagan, Gary Price, Nigel Deeks, British Journal of Pharmacology	2000	281
A Novel, Potent, and Selective 5-HT<sub>7</sub>Antagonist: (<i>R</i>)-3-(2-(2-(4-Methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl)phenol (SB-269970) Peter J. Lovell, Steven M. Bromidge, Steven Dabbs, Journal of Medicinal Chemistry Molecular PharmacologyMedicinal ChemistryPharmaceutical ScienceTranslational PharmacologyBiochemistry	2000	248
SB-399885 is a potent, selective 5-HT6 receptor antagonist with cognitive enhancing properties in aged rat water maze and novel object recognition models Warren D. Hirst, Tania O. Stean, Derek C. Rogers, European Journal of Pharmacology Cognitive ScienceNeuropsychologyCognitive NeuroscienceBehavioral NeuroscienceBrain Function	2006	228
5-Chloro-<i>N</i>-(4-methoxy-3-piperazin-1-yl- phenyl)-3-methyl-2-benzothiophenesulfon- amide (SB-271046): A Potent, Selective, and Orally Bioavailable 5-HT<sub>6</sub> Receptor Antagonist Steven M. Bromidge, Anthony M. Brown, Stephen E. Clarke, Journal of Medicinal Chemistry Drug TargetAltmetric Attention Score4-Methoxy-3-piperazin-1-yl- PhenylPharmacotherapySystem Pharmacology	1999	170
Binding Mode and Structure–Activity Relationships around Direct Inhibitors of the Nrf2–Keap1 Complex Eric Jnoff, Claudia Albrecht, John J. Barker, ChemMedChem	2014	168
Characterization of SB‐271046: A potent, selective and orally active 5‐HT<sub>6</sub> receptor antagonist Carol Routledge, Steven M. Bromidge, Stephen F. Moss, British Journal of Pharmacology Receptors Sb-271046PharmacotherapyExperimental PharmacologyActive 5‐HtRat Mest Test	2000	136
Characterization of [<sup>125</sup>I]‐SB‐258585 binding to human recombinant and native 5‐HT<sub>6</sub> receptors in rat, pig and human brain tissue Warren D. Hirst, Jayne A.L. Minton, Steven M. Bromidge, British Journal of Pharmacology	2000	120
SB-243213; a selective 5-HT2C receptor inverse agonist with improved anxiolytic profile: lack of tolerance and withdrawal anxiety Martyn Wood, Charlie Reavill, Brenda Trail, Neuropharmacology Molecular PharmacologyWithdrawal AnxietyPsychiatryFunctional SelectivityAddiction	2001	100
6-Chloro-5-methyl-1-[[2-[(2-methyl-3- pyridyl)oxy]-5-pyridyl]carbamoyl]indoline (SB-242084): The First Selective and Brain Penetrant 5-HT<sub>2C</sub> Receptor Antagonist Steven M. Bromidge, Malcolm Duckworth, Ian T. Forbes, Journal of Medicinal Chemistry Altmetric Attention ScorePharmacotherapyChemical BiologyExperimental PharmacologyPharmaceutical Chemistry	1997	84

Page 1